NFE2L2 and B-cell chronic lymphocytic leukemia: It was shown that thiol-reactive compounds activated NRF2-mediated signaling less extensively in malignant and normal B-cells as compared to other subpopulations of leukocytes and were more cytotoxic to CLL cells (37).